Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

NCT03003039 is registered in ClinicalTrials.gov with Nanjing Yoko Biomedical Co., Ltd. as lead sponsor.

NCT NCT03003039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03003039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
Lead sponsor
Nanjing Yoko Biomedical Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
June 5, 2017
Completion date
May 20, 2019
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell lymphoma